Lona Biotherapeutics

The submission describes a high-potential biotech project (Lona Biotherapeutics) but contains critically disqualifying claims. While the domain lonabio.com exists and points to a legitimate-looking early-stage biotech entity, the submission's claim that 'most people have used my product' is demonstrably false for a specialized TCR-T cancer therapy. Additionally, the stated market cap of 500,000 is incongruent with a clinical-stage biotech firm, suggesting this may be a low-effort submission, a crypto-token wrapper (potentially linked to 'Lona by Virtuals'), or a project with no verifiable traction. The 'everyone' audience claim further demonstrates a lack of market understanding.